The Role of Lipids and Lipoproteins in Health

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Lipids".

Deadline for manuscript submissions: 25 August 2024 | Viewed by 646

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medicine, University of Washington, Seattle, WA, USA
Interests: mass spectrometry based proteomics; HDL, lipid metabolism and CVD risk in diabetes and kidney disease; oxidative stress and carbonyl stress in human diseases

Special Issue Information

Dear Colleagues,

Lipids are important for human health as they are carried and transported by lipoproteins to different tissues for normal cellular functions. However, blood lipid imbalance or dyslipidemia is harmful and can lead to various disorders. The most important lipoprotein-related diseases are heart disease and other cardiovascular diseases (CVD), which are the leading causes of death worldwide. There are different categories and types of lipoproteins, each playing a different role in cardiovascular diseases. For example, a key process in the pathogenesis of atherosclerosis, the major cause of heart attacks and peripheral vascular disease, is the accumulation of cholesterol-laden macrophages in the artery wall. Thus, one of the factors greatly increasing the risk of atherosclerotic cardiovascular disease is elevated levels of low-density lipoprotein (LDL), which delivers cholesterol to macrophages. In contrast, clinical, epidemiological, and animal studies have demonstrated a strong inverse relationship between high-density lipoprotein cholesterol (HDL-C) levels and CVD risk, strongly supporting the proposal that HDL is antiatherogenic. However, recent studies demonstrated that HDL functions (particularly cholesterol efflux capacity), HDL particle concentration, and HDL proteome are more important for the antiatherogenic properties of HDL than HDL-C levels.

In addition to cardiovascular diseases, lipoproteins play an important role in many other disorders, especially in diabetes and chronic kidney disease (CKD). Diabetic dyslipidemia is characterized by low HDL-C, elevated triglycerides, and elevated LDL-C, particularly small and dense LDL particles. These lipid changes represent a major link between diabetes and increased cardiovascular risk in diabetic patients. CKD patients also exhibit hypertriglyceridemia and low HDL-C levels; however, their LDL-C levels are mostly normal, as opposed to diabetic patients. Therefore, lower HDL levels in CKD patients might be a reason for the dramatically increased CVD risk and progression of CKD stages.

Despite advances in the study of lipoprotein metabolism, their functions, and their impact on disease over the past a few decades, the causal relationship between lipoproteins and different human diseases, as well as the underlying pathophysiological mechanisms remain unclear.

The purpose of this Special Issue is to publish new original discoveries and review articles to deepen our understanding of the role of different types of lipoproteins in the pathogenesis of various human diseases. It aims to identify innovative therapeutic strategies for the prevention or treatment of these diseases.

Dr. Baohai Shao
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lipids
  • lipoproteins
  • cholesterol
  • high-density lipoprotein (HDL)
  • atherosclerosis
  • cardiovascular disease (CVD)
  • chronic kidney disease
  • inflammation
  • low-density lipoprotein (LDL)
  • metabolic syndrome
  • diabetes
  • dyslipidemia

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 588 KiB  
Article
Triglyceride to HDL Cholesterol Ratio for the Identification of MASLD in Obesity: A Liver Biopsy-Based Case-Control Study
by José Ignacio Martínez-Montoro, María Antonia Martínez-Sánchez, Andrés Balaguer-Román, Virginia Esperanza Fernández-Ruiz, José Emilio Hernández-Barceló, Mercedes Ferrer-Gómez, María Dolores Frutos, María Ángeles Núñez-Sánchez, José Carlos Fernández-García and Bruno Ramos-Molina
Nutrients 2024, 16(9), 1310; https://doi.org/10.3390/nu16091310 - 27 Apr 2024
Viewed by 489
Abstract
Associations between dyslipidemia and metabolic dysfunction-associated steatotic liver disease (MASLD) have been reported. Previous studies have shown that the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio may be a surrogate marker of MASLD, assessed by liver ultrasound. However, no studies have evaluated the [...] Read more.
Associations between dyslipidemia and metabolic dysfunction-associated steatotic liver disease (MASLD) have been reported. Previous studies have shown that the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio may be a surrogate marker of MASLD, assessed by liver ultrasound. However, no studies have evaluated the utility of this ratio according to biopsy-proven MASLD and its stages. Therefore, our aim was to evaluate if the TG/HDL-C ratio allows for the identification of biopsy-proven MASLD in patients with obesity. We conducted a case-control study in 153 patients with obesity who underwent metabolic surgery and had a concomitant liver biopsy. Fifty-three patients were classified as no MASLD, 45 patients as metabolic dysfunction-associated steatotic liver—MASL, and 55 patients as metabolic dysfunction-associated steatohepatitis—MASH. A receiver operating characteristic (ROC) analysis was performed to assess the accuracy of the TG/HDL-C ratio to detect MASLD. We also compared the area under the curve (AUC) of the TG/HDL-C ratio, serum TG, and HDL-C. A higher TG/HDL-C ratio was observed among patients with MASLD, compared with patients without MASLD. No differences in the TG/HDL-C ratio were found between participants with MASL and MASH. The greatest AUC was observed for the TG/HDL-C ratio (AUC 0.747, p < 0.001) with a cut-off point of 3.7 for detecting MASLD (sensitivity = 70%; specificity = 74.5%). However, no statistically significant differences between the AUC of the TG/HDL-C ratio and TG or HDL-C were observed to detect MASLD. In conclusion, although an elevated TG/HDL-C ratio can be found in patients with MASLD, this marker did not improve the detection of MASLD in our study population, compared with either serum TG or HDL-C. Full article
(This article belongs to the Special Issue The Role of Lipids and Lipoproteins in Health)
Show Figures

Figure 1

Back to TopTop